Dallas, TX -- (SBWIRE) -- 01/11/2011 -- This model provides detailed sales and volume forecast data for the inflammatory bowel disease market. Including Crohn's disease and ulcerative colitis market sizing, within the context of total brand sales across the seven major markets.

Reasons to Purchase

Quantify the current size of IBD sales in the seven major markets and understand trends in the rest of the world
Understand IBD market trends and assess the impact of events, such as biosimilars entry, on sales of over 30 key brand name products
Access a case study assessing the likelihood of ulcerative colitis approval for Humira and Simponi with three alternative scenario forecasts
Buy Now: Market Research

Related Reports

Forecast Insight: Inflammatory Bowel Disease - New product launches sustain long-term market growth
Commercial Insight: Inflammatory Bowel Disease Future market prospects rely on addressing cost and safety
Pipeline Insight: Inflammatory Bowel Disease - Varied drug targets to broaden future therapy options
Inflammatory Bowel Disease Therapy Area Pipeline Report
Digestive System Inflammatory Bowel Disease Therapy Area Pipeline Report
Irritable Bowel Syndrome - Pipeline Assessment and Market Forecasts to 2017
Irritable Bowel Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016
The Future of Parenteral Nutrition: Key players, disease specific opportunities and market forecasts
Parkinson's Disease Market Forecast
Chronic Kidney Disease - Pipeline Assessment and Market Forecasts to 2016

About ReportsnReports
ReportsnReports comprises of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.